Skip to main content
. 2020 Jan 29;14(1):e0008039. doi: 10.1371/journal.pntd.0008039

Fig 5. Differential serological diagnosis of TBEV.

Fig 5

A and B) Detection of IgM (A) IgG (B) antibodies by TBEV rNS1-based ELISA using sera samples from five different groups of sera samples: 10 sera samples of healthy individuals from non-endemic TBEV regions and 3 sera from YFV vaccinated individuals (TBEV non-endemic areas) were used as controls. TBEV vaccinated group corresponds to 10 sera from individuals who got the vaccine (a suspension of purified TBE inactivated virus). The acute group corresponds to individuals with acute TBEV infection. The vaccine breakthrough (VBT) group corresponds to individuals who got the vaccine and were also infected with TBEV. * each ELISA result includes the average of two biological replicates.